ACIU AC Immune Quarterly Revenue Growth

Corporate company logo of AC Immune (ACIU)

Geopolitical tensions and sanctions are limiting the export of AC Immune (ACIU) neuro-drugs, narrowing its target markets. Reviewing the quarterly revenue changes on GURU.Markets, it is evident that 239.10 determines the current status of the parameter. This is based on confidence in scientific management and partner co-financing, as well as low demand elasticity driven by the unique Morphomer platform for combating Alzheimer's disease.

ACIU (AC Immune S.A.) Quarterly Sales Growth history from 07/04/2022 to 11/20/2026

Summary analytical data breakdowns for AC Immune S.A. (ACIU)

- stock price and consensus target price:
Fundamental valuation:AC Immune S.A. (ACIU)
Flagship merchandise of AC Immune SA

For the pharmaceutical business of AC Immune (ACIU), the quarterly revenue trend serves as an indicator of commercial resilience in the development of antibodies against neurodegenerative diseases. This metric measures sales growth rates, assessing cash flow momentum and the company's ability to scale therapy for chronic patients. The calculation is based on a comparison of current quarterly income with the same period last year to neutralize seasonality. Stable growth confirms the effectiveness of patent protection and reduces the risk of asset impairment.

Main competitors

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|AMLX: Quarterly Revenue Growth|TRVI: Sales Change QoQ|Revenue Growth QoQ Praxis Medicines|Quarterly Revenue Growth Rate Anavex AVXL|Revenue Growth QoQ CeriBell Corp (CBLL)|Sales Change QoQ PRTA|Quarterly Revenue Growth ALEC (Alector)|Annexon (ANNX) - Quarterly Revenue Growth Rate|OMER - Revenue Growth QoQ|NGNE (Neurogene) - Sales Growth QoQ|Voyager Corp (VYGR) - Revenue Growth QoQ|NMRA - Quarterly Sales Growth Rate|Revenue Growth QoQ Scilex|TVGN (Tevogen Bio) - Sales Change QoQ|Quarterly Sales Growth ACOG (alphacognition.com)|Quarterly Sales Growth Rate Cognition Therapeutics, Inc.|Quarterly Revenue Growth IKT (Inhibikase Pharma)|Quarterly Revenue Growth Cassava Sciences, Inc. SAVA|ASRT - Revenue Growth QoQ|Quarterly Revenue Growth Rate Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Revenue Growth QoQ|OVID - Quarterly Sales Growth Rate|Revenue Growth QoQ Acumen Pharmaceuticals, Inc|Revenue Growth QoQ CRVO|Quarterly Revenue Growth ATHE|Clene - Sales Growth QoQ|Quarterly Revenue Growth PEPG (pepgen.com)|JUNS: Sales Growth QoQ|RLMD - Revenue Growth QoQ|Quarterly Revenue Growth Rate Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Quarterly Sales Growth|Quarterly Revenue Growth Rate Firefly Neuroscience (AIFF)|Quarterly Sales Growth KLTO|NRSN: Quarterly Revenue Increase|Revenue Growth QoQ Reviva Pharmaceuticals Holdings (RVPH)|Quarterly Sales Growth MetaVia, Inc. MTVA|Revenue Growth QoQ NeurAxis NRXS|HSDT: Sales Growth QoQ|passagebio.com - Quarterly Revenue Growth|NEUP - Quarterly Revenue Growth|Minerva Neurosciences Corp (NERV) - Revenue Growth QoQ|Revenue Dynamics QoQ ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Quarterly Revenue Growth|Sales Growth QoQ ALZN (Alzamend Neuro)|Revenue Growth QoQ Cyclerion Therapeutics Inc. (CYCN)|Quarterly Revenue Growth Protagenic Therapeutics, Inc. (PTIX)|Quarterly Revenue Growth KTTA (Pasithea Therapeutics Corp)|CRGT - Quarterly Sales Growth|ATXI - Revenue Growth QoQ|BCLI: Revenue Growth QoQ|Cara Therapeutics (CARA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Chromocell Therapeutics Corp (CHRO)|Quarterly Sales Growth ELYM|Quarterly Revenue Growth Rate intracellulartherapies.com ITCI|Revenue Growth QoQ Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Quarterly Revenue Increase|Revenue Growth QoQ NKGen NKGN|Quarterly Revenue Growth NeuroBo Pharmaceuticals Inc NRBO|SAGE: Quarterly Sales Growth|Quarterly Sales Growth Rate Synaptogenix, Inc SNPX|TRVN: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ